Publications by authors named "Robert Hoerr"

Claim this Profile
extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
Matthias Riepe, Robert Hoerr, Sandra Schlaefke

World J Biol Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defined Ginkgo Biloba Extract for Adults with Major Neurocognitive Disorder.
Debashish Chowdhury, Ajit Kumar Roy, V Radhika Reddy, Yogesh Kumar Gupta, Pushkar Nigam, Robert Hoerr

Dement Geriatr Cogn Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
Jakub Hort, Thomas Duning, Robert Hoerr

Neuropsychiatr Dis Treat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single and Repeated Doses of EGb 761 do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects.
Robert Hoerr, Andrea Zimmermann, Friedeborg Seitz, Angelika Dienel

Front Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGb 761 Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer's Dementia-Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial.
Charlotte Kloft, Robert Hoerr

Healthcare (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of the Ginkgo special extract EGb761 within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease.
Walter E Müller, Anne Eckert, Gunter P Eckert, Heidrun Fink, Kristina Friedland, Robert Hoerr

World J Biol Psychiatry· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
extract EGb 761 alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trials.
Rainer Spiegel, Roger Kalla, Georgios Mantokoudis, Raphael Maire, Heiko Mueller, Robert Hoerr

Clin Interv Aging· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
Egemen Savaskan, Heiko Mueller, Robert Hoerr, Armin von Gunten, Serge Gauthier

Int Psychogeriatr· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report.
Régis Bordet, Ralf Ihl, Amos D Korczyn, Giuseppe Lanza, Jelka Jansa, Robert Hoerr

BMC Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761(®).
Robert Hoerr, Michael Zaudig

Eur Arch Psychiatry Clin Neurosci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to change of composite and frequency scores of the neuropsychiatric inventory in mild cognitive impairment.
Jeffrey L Cummings, Michael Tribanek, Robert Hoerr

Int Psychogeriatr· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine.
Larysa Sokolova, Robert Hoerr, Tamara Mishchenko

Int J Otolaryngol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.
Leili Fatehi, Susan M Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Robert A Hoerr

J Law Med Ethics· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
Gillian Douglas, Erik Van Kampen, Ashley B Hale, Eileen McNeill, Jyoti Patel, Robert A Hoerr

Eur Heart J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia.
Jeffrey L Cummings, Ralf Ihl, Horst Herrschaft, Robert Hoerr, Michael Tribanek

Int Psychogeriatr· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Horst Herrschaft, Anatol Nacu, Sergey Likhachev, Ilya Sholomov, Robert Hoerr

J Psychiatr Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
Ralf Ihl, Natalia Bachinskaya, Amos D Korczyn, Veronika Vakhapova, Michael Tribanek, Robert Hoerr

Int J Geriatr Psychiatry· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
Natalia Bachinskaya, Robert Hoerr, Ralf Ihl

Neuropsychiatr Dis Treat· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the coating morphology on the drug release from engineered drug-polymer nanocomposites.
Jinping Dong, Chris Frethem, Greg Haugstad, Robert A Hoerr, John D Foley

Annu Int Conf IEEE Eng Med Biol Soc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-eluting stent coatings.
Judit E Puskas, Lyn G Muñoz-Robledo, Robert A Hoerr, John Foley, Steven P Schmidt

Wiley Interdiscip Rev Nanomed Nanobiotechnol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginkgo biloba does not reduce incidence of dementia in elderly people.
Robert Hoerr

Evid Based Ment Health· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal dynamic imaging of therapeutic biomedical coatings in aqueous medium.
Jinping Dong, John D Foley, Chris D Frethem, Robert A Hoerr, Michael J Matuszewski

Langmuir· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis.
Leo R Fitzpatrick, Jeffrey Small, Robert A Hoerr, Eileen F Bostwick, Lynn Maines

Br J Nutr· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
Lon S Schneider, Steven T DeKosky, Martin R Farlow, Pierre N Tariot, Robert Hoerr

Curr Alzheimer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment.
Robert Hoerr, Michael Noeldner

CNS Drug Rev· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis